Trial NCT03439033

View at ClinicalTrials.gov 
Org. Study IDs: 1706018301

Last trial update was posted on 2023-03-13

MeSH Interventions

Edetic Acid N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Prostate Cancer

Stopping Reasons

Study Drug was FDA approved Summer 2021

Limitations And Caveats

One limitation is the small number of cases available for specificity analysis resulting in a negligible sample size of patients who had a true negative reference. Another limitation is multiple patients sought care at other institutions. As a result, information was not complete for several patients. Only a small number of the subjects had 2-year follow-up or underwent confirmatory biopsy, which introduces the possibility of selection bias.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID